THIOTEPA - (PWS 15 MG/VIAL) DIN 02174391
Status: Cancelled Post Market
Holder: WYETH CANADA
Health Canada record
| Active ingredient(s) | THIOTEPA 15 MG |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Intracavitary; Intravesicular; Intravenous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01AC01 THIOTEPA |
|---|
| Original market date | 25-Aug-1997 |
|---|
| Current status date | 15-Sep-2004 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing THIOTEPA
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02567059 | TEPADINA | ADIENNE SA | Powder For Solution | THIOTEPA 200 MG | Approved |
| 02462680 | TEPADINA | ADIENNE SA | Powder For Solution | THIOTEPA 15 MG | Marketed |
| 02462702 | TEPADINA | ADIENNE SA | Powder For Solution | THIOTEPA 100 MG | Marketed |
| 02526417 | THIOTEPA FOR INJECTION USP | STERIMAX INC | Powder For Solution | THIOTEPA 15 MG | Marketed |
| 02526425 | THIOTEPA FOR INJECTION USP | STERIMAX INC | Powder For Solution | THIOTEPA 100 MG | Marketed |
| 02536862 | THIOTEPA FOR INJECTION, BP | HIKMA CANADA LIMITED | Powder For Solution | THIOTEPA 15 MG | Marketed |
| 02536870 | THIOTEPA FOR INJECTION, BP | HIKMA CANADA LIMITED | Powder For Solution | THIOTEPA 100 MG | Marketed |
| 02523906 | TEPADINA | ADIENNE SA | Powder For Solution | THIOTEPA 400 MG | Dormant |
| 00237035 | THIO TEPA INJ 15MG/VIAL | LEDERLE CYANAMID CANADA INC. | Powder For Solution | THIOTEPA 15 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 3617 | 2003-04-23 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for THIOTEPA
7 active FDA Drug Master Files.
Request a quote for THIOTEPA - (PWS 15 MG/VIAL)
How to read a Canadian DIN record